Sort   by:  
 Page size 
2-hydroxyglutarate (2-HG) is an oncometabolite accumulating in certain cancers and some neurometabolic diseases. In cancers 2-HG accumulation is induced by a gain-of-function mutation in isocitrate dehydrogenase (IDH) genes, leading to conversion of alpha-ketoglutarate (a-KG) into 2-HG
ORGANISM(S): Saccharomyces cerevisiae S288C 
Mitochondria play a crucial role in regulating cellular homeostasis in response to intrinsic and extrinsic cues by changing cellular metabolism to meet these challenges. However, the molecular underpinnings of this regulation and the complete spectrum of these physiological outcomes remain largely u...
ORGANISM(S): Mus musculus (Mouse) 
2025-05-26 | PXD064288 | Pride
Isocitrate dehydrogenase (IDH) mutations, a hallmark of gliomagenesis, result in the production of the oncometabolite R-2-hydroxyglutarate (R-2-HG) which is thought to promote tumorigenesis via DNA methylation. Here we identify an additional immunosuppressive activity of R-2-HG: Tumor cell-derived R...
ORGANISM(S): Homo sapiens 
2-hydroxyglutarate modulates histone methylation using both RNA/ChIP-seq
R-2-hydroxyglutarate-mediated inhibition of KDM4A disrupts telomere integrity
Mitochondrial L-2-hydroxyglutarate is a physiologic signaling metabolite [CUT&Run]
Mitochondrial L-2-hydroxyglutarate is a physiologic signaling metabolite [mRRBS]
Sort   by:  
 Page size